In accordance with IFNγ release, EC17 also triggered CAR-T cell expansion identified as human CD3ε+ EGFRt+ events in mouse blood, and cells persisted up to 54 days in tumor-bearing animals (last measurement) (Figure 6C). This evidence concerns the gene CD3E and neoplasm.